Abstract:Abstract Mutations in the pituitary specific transcription factor Prophet of Pit-1 (PROP1) are the most common genetic etiology of combined pituitary hormone deficiency (CPHD), which affects 1 in 8,000 newborns worldwide. CPHD is associated with short stature, attributable to growth hormone (GH) deficiency and/or thyroid stimulating hormone (TSH) deficiency. Pathogenic lesions impair pituitary development and differentiation of endocrine cells. Prop1-mutant mice show increased expression of genes including SRY-Box Transcription Factor 21 (Sox21) and Pou Domain, Class 3, Transcription Factor 4 (Pou3f4). POU3F4 is expressed in the developing inner ear and restricts the proliferation and lineage potential of neural stem cells. Genetic defects cause non-syndromic X-linked deafness (DFNX2) in humans and mice. The function of POU3F4 in pituitary development is largely unknown and the implications of its overexpression in Prop1-mutant pituitaries remain unexplored. Therefore, we aim to address the role of Pou3f4 in pituitary development and determine the contributions of Pou3f4 upregulation to pituitary disease by utilizing Pou3f4-mutant mice as well as double mutant mice lacking both Prop1 and Pou3f4. Utilizing immunofluorescent analysis at critical timepoints during pituitary development, we have characterized the timeline for endogenous POU3F4 expression. Initial expression is detected at e11.5 in differentiating cells on the ventral side of Rathke's pouch and is restricted to the proliferating anterior lobe at e13.5, continuing postnatally, similar to previously published expression data. POU3F4 expression then decreases and becomes gradually restricted to the periluminal stem cell niche at e15.5 and p0. We further validated the upregulation of POU3F4 in histological sections of Prop1-mutant mice at e15 and p0, finding increased expression in the developing anterior lobe of mutants compared to wildtypes. Single-cell regulatory network inference and clustering (SCENIC) analyses, which utilize single-cell transcription factor co-expression with potential direct downstream targets that contain the corresponding transcription factors’ binding sequence to infer active transcription networks, predict increased activity of the Pou3f4 gene regulatory network in a subpopulation of Sox2-expressing stem cells in Prop1-mutant mice. Preliminary analyses indicate that Pou3f4 mutant have normal morphology at P1, together with grossly normal expression of Sox2 and Pou1f1. We are performing quantitative PCR to determine possible compensatory mechanisms in response to loss of Pou3f4 expression. To investigate whether any Prop1-mutant phenotypes, including dysmorphology and ectopic expression of Sox21 and Otog, are attributable to Pou3f4 upregulation, we are studying Pou3f4;Prop1 mice. We will determine the impacts of POU3F4 upregulation on cellular morphology, stem cell maintenance and endocrine cell differentiation. The mechanisms of action in the regulation of stem cell differentiation constitutes a gap in our current understanding of the pathogenesis of CPHD. These studies will provide novel insights into the mechanistic function of Pou3f4 during embryonic pituitary development and potential novel etiologies of CPHD in human patients. Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.

Pou2f1 and Pou2f2 cooperate to control the timing of cone photoreceptor production in the developing mouse retina

Coup-Tfs Regulate Eye Development by Controlling Factors Essential for Optic Vesicle Morphogenesis

Pou4f2/Brn3b Overexpression Promotes The Genesis Of Retinal Ganglion Cell-Like Projection Neurons From Late Progenitors

The Spatial Patterning Of Mouse Cone Opsin Expression Is Regulated By Bone Morphogenetic Protein Signaling Through Downstream Effector Coup-Tf Nuclear Receptors (October, Pg 12401, 2009)

Characterization of new otic enhancers of the pou3f4 gene reveal distinct signaling pathway regulation and spatio-temporal patterns

Two transcription factors, Pou4f2 and Isl1, are sufficient to specify the retinal ganglion cell fate

is a novel retinal developmental gene that promotes cone photoreceptor differentiation through inhibition of alternative rod photoreceptor fates

The Transcription Factor Pou3f1 Promotes Neural Fate Commitment Via Activation of Neural Lineage Genes and Inhibition of External Signaling Pathways

Genome-wide ChIP-seq and RNA-seq Analyses of Pou3f1 During Mouse Pluripotent Stem Cell Neural Fate Commitment

POU6F2, a risk factor for glaucoma, myopia and dyslexia, labels specific populations of retinal ganglion cells

SUN-050 the Evolutionarily Conserved Function of COUP-TF Genes in the Differentiation of Photoreceptor Cells in the Retina

Ptf1a Determines Horizontal and Amacrine Cell Fates During Mouse Retinal Development

Pou3f4-mediated regulation of ephrin-b2 controls temporal bone development in the mouse

PMON145 The Role of Pou3f4 in Pituitary Development and Disease

Foxn4 is a Temporal Identity Factor Conferring Mid/late-Early Retinal Competence and Involved in Retinal Synaptogenesis

Murine Retina Outer Plexiform Layer Development and Transcriptome Analysis of Pre-Synapses in Photoreceptors

Cell fate specification and conversion generate foveolar cone subtype patterning in human retinal organoids

Pou3f4‐expressing otic mesenchyme cells promote spiral ganglion neuron survival in the postnatal mouse cochlea

Jarid2 Promotes Temporal Progression of Retinal Progenitors Via Repression of Foxp1.

A long range distal enhancer controls temporal fine-tuning of PAX6 expression in neuronal precursors

Polycomb Repressive Complex PRC2 Regulates Xenopus Retina Development Downstream of Wnt/β-catenin Signaling.